Quantitative pulldown with APD-CLD probe identifies covalent binding targets.

Published: 4 August 2018| Version 1 | DOI: 10.17632/2mx2hmw6ds.1
Contributors:
Kristian Mark Jacobsen,
Nikolaj Villadsen,
Christian Sibbersen,
Carsten Scavenius,
Jan J. Enghild,
Mogens Johannsen,
Thomas B. Poulsen

Description

Figure 2b: PANC-1 cells were treated with an APD-CLD alkyne probe or an APD-CLD-deficient alkyne probe (125-1000 nM, 2-fold dilution) for 12 hours under hypoxia. The lysates were tagged with rhodamine-N3 via CuAAC, separated by electrophoresis and visualized by excitation of rhodamine B. Figure 2c: Protein targets in living PANC-1 cells were enriched by CuAAC to biotin-PEG3-N3 followed by pulldown on streptavidin-coated Dynabeads. The enriched proteins were separated by electrophoresis and visualized by SimplyBlue Safe Stain. Figure S2a: In-gel fluorescence analysis of covalent binding partners for the APD-CLD alkyne probe. PANC-1 cells were treated with siRNA against RTN3, RTN4, CYB5B or non-targeting control siRNA, and subsequently treated with an APD-CLD alkyne probe for 12 hours under hypoxia. Then cells were lysed and lysates were tagged by CuAAC to rhodamine B azide. The proteins were separated by SDS-PAGE and analyzed for fluorescence in a CCD camera. Subsequently, the gel was stained by SimplyBlue SafeStain for total protein visualisation. Figure S2c,d,e,f: See [Viability data.xlsx]. Cells were treated with either the APD-CLD alkyne probe or electrophilic acrylamide RTN4 ligands for 48 hours under normoxia or hypoxia. Viability was assessed by CellTIter Blue (Promega) and is given as RFUs.

Files

Institutions

Aarhus Universitet Institut for Kemi

Categories

Affinity Labeling

License